The following represents disclosure information provided by authors of this abstract. The Breast Cancer Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Identifying genomic rearrangements in BRCA1 and BRCA2 in high-risk individuals for hereditary breast and ovarian cancer.
M. Jackson
No relevant relationships to disclose
D. Mattair
No relevant relationships to disclose
H. Lin
No relevant relationships to disclose
A. M. Gutierrez-Barrera
No relevant relationships to disclose
N. Elsayegh
No relevant relationships to disclose
J. K. Litton
No relevant relationships to disclose
G. N. Hortobagyi
No relevant relationships to disclose
B. Arun
No relevant relationships to disclose